Cullinan Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $88.3M | $83.0M | $98.4M | $156.2M | $59.8M | $168.2M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $386.8M | $414.7M | $480.2M | $474.5M | $296.6M | $212.3M |
| Property, Plant & Equipment | $421.0K | $683.0K | $989.0K | $1.2M | $77.0K | $130.0K |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $448.4M | $621.8M | $484.2M | $561.1M | $437.2M | $214.7M |
| Liabilities | ||||||
| Accounts Payable | $841.0K | $1.7M | $2.5M | $2.7M | $3.2M | $9.7M |
| Total Current Liabilities | $37.7M | $30.6M | $28.1M | $22.5M | $11.7M | $14.3M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $39.6M | $31.5M | $30.3M | $26.1M | $11.8M | $14.4M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-588.1M | $-368.2M | $-200.9M | $-47.7M | $-158.9M | $-93.3M |
| Total Stockholders' Equity | $408.7M | $590.3M | $453.7M | $535.0M | $425.0M | $199.0M |